Clustering of ABCB1 and CYP2C19 Genetic Variants Predicts Risk of Major Bleeding and Thrombotic Events in Elderly Patients with Acute Coronary Syndrome Receiving Dual Antiplatelet Therapy with Aspirin and Clopidogrel

被引：0
|
作者：
Roberta Galeazzi
Fabiola Olivieri
Liana Spazzafumo
Giuseppina Rose
Alberto Montesanto
Simona Giovagnetti
Sara Cecchini
Gelsomina Malatesta
Raffaele Di Pillo
Roberto Antonicelli
机构：
[1] INRCA National Institute,Clinical Laboratory and Molecular Diagnostics
[2] DISCLIMO,Department of Clinical and Molecular Sciences
[3] Università Politecnica delle Marche,Center of Clinical Pathology and Innovative Therapy
[4] INRCA National Institute,Center of Biostatistics
[5] INRCA National Institute,Department of Biology, Ecology and Earth Sciences
[6] University of Calabria,Unit of Radiology
[7] National Institute of Health and Science on Aging (INRCA),Cardiology Unit
[8] National Institute of Health and Science on Aging (INRCA),undefined
来源：
Drugs & Aging | 2018年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：649 / 656
页数：7
相关论文
共 50 条
  • [31] Sex-related bleeding risk in acute coronary syndrome patients receiving dual antiplatelet therapy with aspirin and a P2Y12 inhibitor.
    ten Haaf, Monique E. E.
    van Geuns, Robert-Jan M.
    van der Linden, Marc M. J. M.
    Smits, Pieter C. C.
    de Vries, Arie G. G.
    Doevendans, Pieter A. A.
    Appelman, Yolande
    Boersma, Eric
    MEDICAL PRINCIPLES AND PRACTICE, 2023, 32 (03) : 200 - 208
  • [32] Influence of CYP2C19, ABCB1 and PON1 genotypes on the plasma concentrations of clopidogrel metabolite and platelet aggregation in patients after coronary stenting (PCI)
    Barbara Gawrońska-Szklarz
    Anna Czerkawska
    Urszula Adamiak-Giera
    Szymon Olędzki
    Mateusz Kurzawski
    Maria Jastrzębska
    Krzysztof Safranow
    Zdzisława Kornacewicz-Jach
    Pharmacological Reports, 2013, 65 (Suppl 1) : 46 - 46
  • [33] IMPACT OF THE CYP3A4 METABOLIC ACTIVITY AND CYP2C19 POLYMORPHISMS ON ANTIPLATELET EFFECTS OF CLOPIDOGREL IN RUSSIAN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING CORONARY STENT IMPLANTATION
    Mirzaev, K. B.
    Sychev, D. A.
    Andreev, D. A.
    Kazakov, R. E.
    Smirnov, V. V.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E78 - E78
  • [34] Impact of point-of-care testing for CYP2C19 on platelet inhibition in patients with acute coronary syndrome and early dual antiplatelet therapy in the emergency setting
    Stimpfle, Fabian
    Karathanos, Athanasios
    Droppa, Michal
    Metzger, Janina
    Rath, Dominik
    Mueller, Karin
    Tavlaki, Elli
    Schaeffeler, Elke
    Winter, Stefan
    Schwab, Matthias
    Gawaz, Meinrad
    Geisler, Tobias
    THROMBOSIS RESEARCH, 2014, 134 (01) : 105 - 110
  • [35] Effects of CYP2C19 LoF allele on major adverse cardiovascular events associated with clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention: meta-analysis
    Biswas, Mohitosh
    Sukasem, Chonlaphat
    Khatun Kali, Most Sumaiya
    Ibrahim, Baharudin
    PHARMACOGENOMICS, 2021, 23 (03) : 207 - 220
  • [36] Influence of CYP2C19 loss-of-function variants on the antiplatelet effects and cardiovascular events in clopidogrel-treated Chinese patients undergoing percutaneous coronary intervention
    Jian-Jun Zou
    Hong-Guang Xie
    Shao-Liang Chen
    Jie Tan
    Ling Lin
    Ying-Ying Zhao
    Hai-Mei Xu
    Song Lin
    Juan Zhang
    Guang-Ji Wang
    European Journal of Clinical Pharmacology, 2013, 69 : 771 - 777
  • [37] Influence of CYP2C19 loss-of-function variants on the antiplatelet effects and cardiovascular events in clopidogrel-treated Chinese patients undergoing percutaneous coronary intervention
    Zou, Jian-Jun
    Xie, Hong-Guang
    Chen, Shao-Liang
    Tan, Jie
    Lin, Ling
    Zhao, Ying-Ying
    Xu, Hai-Mei
    Lin, Song
    Zhang, Juan
    Wang, Guang-Ji
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (04) : 771 - 777
  • [38] CYP2C19 LOF and GOF-Guided Antiplatelet Therapy in Patients with Acute Coronary Syndrome: A Cost-Effectiveness Analysis
    Jiang, Minghuan
    You, Joyce H. S.
    CARDIOVASCULAR DRUGS AND THERAPY, 2017, 31 (01) : 39 - 49
  • [39] CYP2C19 LOF and GOF-Guided Antiplatelet Therapy in Patients with Acute Coronary Syndrome: A Cost-Effectiveness Analysis
    Minghuan Jiang
    Joyce H. S. You
    Cardiovascular Drugs and Therapy, 2017, 31 : 39 - 49
  • [40] CYP2C19 genotype plus platelet reactivity-guided antiplatelet therapy in acute coronary syndrome patients: a decision analysis
    Jiang, Minghuan
    You, Joyce H. S.
    PHARMACOGENETICS AND GENOMICS, 2015, 25 (12): : 609 - 617
12345